Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US and Japanese distributors for Raggio-Italgene:

This article was originally published in Clinica

Executive Summary

Italy-based Raggio-Italgene has appointed Oncor (US) and Medical & Biological Laboratories (Japan) as exclusive distributors of its C-Trak kits for lymphoma and leukaemia. Oncor's oncology marketing manager, David Parker, says the C-Trak DNA-probes complement its clinical and research products. MBL, which produces antibodies and antisera, immunoassays and reagents for autoantibodies and plasma proteins, says the agreement will enable it to enter the cancer field. In addition to its marketed C-Trak products for lymphoma, leukaemia and cystic fibrosis, Raggio is developing probes for prostate and breast cancer, ss-thalassaemia and several infectious diseases. The Italian company expects to appoint an exclusive distributor for Europe soon.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT091909

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel